Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Polyus and Polymetal will jointly conduct geological exploration of Lyuginskaya area

4/18/24 PLZL

Slavneft-Megionneftegaz reported for 3 months of 2024 by RAS

4/18/24 MFGS

Himprom reported for 2024 by RAS

4/18/24 HIMCP

VSMPO-AVISMA reported for 3 months in 2024 by RAS

4/18/24 VSMO

Cherkizovo reported for 3 months of 2024 by RAS

4/18/24 GCHE

Mosenergo in Q1 increased electricity generation by 3.8%

4/18/24 MSNG

Board of Directors of Mosgorlombard recommended that dividends be paid for 2023

4/18/24 MGKL

Phosagro allocates to investments a record ₽73 billion

4/18/24 PHOR

PhosAgro sales up 11.5% in Q1

4/18/24 PHOR

Dialext successfully closed the investment raising round

4/18/24 OTCI